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What Is Alzheimer’s Disease?

Alzheimer’s disease (often shortened to “Alzheimer’s” or “AD”) is a brain disease usually
occurring in older people, although it is not a normal part of aging. Alzheimer’s disease causes a
decline in thinking, memory, and language, personality changes, and certain changes in the brain,
that gradually get worse over time. AD eventually results in the loss of ability to carry out the
simplest daily tasks.
Alzheimer’s disease is the most common cause of dementia in old age. “Dementia” refers to a
decline in multiple areas of mental function that interferes with ability to carry out daily
activities. Not all people with dementia have Alzheimer’s disease. The term “Alzheimer’s
disease” is reserved for patients with characteristic changes in the brain that are the hallmarks of
the disease. These brain changes include damage and loss of nerve cells and their connections,
tangled fibers, protein clumps, and inflammation. AD begins deep in the brain, as many as 10 to
20 years before symptoms appear, and gradually spreads to other parts of the brain.
The progression of Alzheimer’s disease occurs in seven stages, according to the Alzheimer’s
Association ( http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp). Stage 1 is “no
impairment.” Stage 2 is marked by “very mild decline;” the person experiences memory lapses
but no symptoms are detected by others or by a medical examination. Such symptoms may be
due to age-related changes and not AD. Stage 3 is “mild cognitive decline,” when others begin to
notice a person’s memory problems. AD may be diagnosed in some, but not all people with mild
cognitive decline. In stages 4-7, the person goes from moderate to severe decline. The
progression and course of AD vary widely from individual to individual. Expert medical opinion
should be sought to diagnose Alzheimer’s disease since other conditions requiring different
treatments may mimic AD or coexist with it.
History
Alzheimer’s disease is not a new condition; the frequent association of dementia and old age was
known to ancient Greek and Roman physicians. However, the characteristic brain lesions found
in people with AD were first described by the German physician Alois Alzheimer and by noted
psychiatrist Emil Kraepelin in the early 20th century. Alzheimer published a classic paper in 1907
describing the tangled fibers and clumps that are now called “neurofibrillary tangles” and
“amyloid plagues,” in the brain of a woman in her fifties with dementia.
Alzheimer’s disease, long considered an obscure neurologic condition, came to the research
forefront in 1976 with the publication of a landmark editorial by Robert Katzman, a leading AD
researcher. In this paper, Katzman argued that “Alzheimer disease” and “senile dementia” were
the same disease and a leading cause of disability and death in the U.S. Before this time, neither

Alzheimer’s disease nor senile dementia had been listed as causes of death in U.S. vital statistics
reports.
Alzheimer’s disease is becoming an issue of increasing public health importance as people live
longer and many countries have aging populations. According to the Alzheimer’s Association,
more than 5 million people are living with Alzheimer’s in the U.S.; by 2050, as many as 16
million may be affected. For the first time since the U.S. government’s Healthy People reports
began in 1979, Healthy People 2020 includes goals and objectives for Alzheimer’s disease.
(HealthyPeople.gov. Dementias Including Alzheimer’s Disease. Accessed 1/13/2011 from
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=7)
What is dementia?
Dementia is a general term for a decline in multiple areas of mental functioning such as memory,
reasoning, and language so extensive that it interferes with daily life. Dementia is not a specific
disease, but rather a group of symptoms that often accompanies a disease or condition.
Two of the most common causes of dementia in older people are Alzheimer’s disease and
vascular dementia. The latter condition is caused by a series of strokes or changes to the brain’s
blood supply. A person may have both AD and vascular dementia.
Other conditions causing memory loss or dementia include:
•
•
•
•
•
•
•
•

Drug side effects
Chronic alcoholism
Brain tumors/infections/blood clots
Vitamin B12 deficiency
Dehydration
High fever
Some thyroid, kidney, or liver disorders
Severe depression

Identifying the cause of dementia is important because this may affect the treatment and
prognosis.
Who gets Alzheimer’s disease and why?
The exact cause of Alzheimer’s disease is not known. Researchers believe that Alzheimer’s
disease usually results from the combination of several genetic, familial, and environmental
factors. Age, family history, and genetics are key risk factors.
The greatest single risk factor for AD is advanced age. For unknown reasons, symptoms usually
begin after age 60. Alzheimer’s disease is found in about 1 in 8 people aged 65 to 74. After age

65, the number of people affected doubles every five years; AD affects nearly half of all people
over 85.
A person’s genetic makeup may also increase his or her risk of AD. In the common form of
Alzheimer’s disease that develops after age 60, certain genes may place a person at higher risk of
AD, but do not make developing the disease inevitable. People with one or two copies of a gene
called APOE-e4, for example, are at increased risk of developing the disease.
A rare, early-onset form of AD appears in family clusters and begins between the ages of 30 and
60. Most cases of early-onset AD are believed to result from genetic mutations; early-onset AD
accounts for less than 5 percent of cases.
Other risk factors for AD are less well established, and may include severe or repeated head
trauma, female gender (partly because women live longer), and cardiovascular disease. Good
health habits and remaining physically and mentally active may delay or slow the course of the
disease.
What is mild cognitive impairment?
People with mild cognitive impairment (MCI) have problems with memory, language, or other
mental functions that are noticeable to others and can be detected by testing, but are not serious
enough to interfere with daily activities. People with MRI have an increased risk of developing
Alzheimer’s disease, especially if their main problem is memory (amnestic MCI).
How do I know if I have/ a loved one has Alzheimer’s disease?
Mild memory problems are sometimes an early sign of Alzheimer’s disease, but may simply be
part of the aging process. The Alzheimer’s Association has compiled a checklist of 10 warning
signs, available online at http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp
AD should be diagnosed only by a physician; local chapters of the Alzheimer’s Association can
help locate an experienced practitioner.
What can I expect if I am/a loved one is diagnosed with Alzheimer’s disease?
Alzheimer’s disease is a progressive disease for which there is no known cure. Certain
medications or other interventions may help relieve symptoms or even slow the progression of
the disease. The type, progression, and severity of mental changes in AD vary greatly. The
course of the disease from the time of diagnosis varies according to age, sex, severity at
diagnosis, and presence of other health conditions. People may live from three to twenty years
after diagnosis. A four-minute captioned video is available at
http://www.nia.nih.gov/Alzheimers/ADVideo/ .
How can I search for Alzheimer’s on the Web?
Selected Web sites (see below under Important Sites)

A good place to begin researching Alzheimer’s on the Web is the U.S. National Library of
Medicine’s MedlinePlus at http://www.nlm.nih.gov/medlineplus/alzheimersdisease.html. This
site has clean, well-designed screens and a wide variety of materials including videos, easy-toread flyers, and information in multiple languages.
The Alzheimer’s Association at http://www.alz.org/ and ADEAR at
http://www.nia.nih.gov/Alzheimers/ are also good one-stop shops.
The resources listed above and some other good Alzheimer’s Web sites are listed under Important Sites.
They give overviews of AD, answer frequently asked questions, and tell what to expect in the early,
middle, and late stages. They can point the user to the latest research and news, help locate doctors and
services, and discuss the latest treatments and clinical trials. They teach caregivers how to help patients
and alleviate the stress of caregiving. These Web sites also help patients, families and friends stay socially
connected through e-mail, discussion groups, forums, blogs, and social media.
Commercial sites also sell products; users must be careful to distinguish educational content from
promotional materials.
Search Engines

Many users prefer to begin their quest with a search engine such as Google
(http://www.google.com) or Yahoo (http://www.yahoo.com/) to search the entire Web, or a
portal such as Healthfinder.gov (http://www.healthfinder.gov/) may be used to search a group of
Web sites. Google Scholar (http://scholar.google.com/ ) is useful when searching for scholarly
articles, and Google Books (http://books.google.com/ ) when looking for books. The user may
wish to restrict his/her search to the most recent five years.
Recommended Search Terms:
•
•
•
•
•
•
•

Alzheimer’s Disease
Alzheimer’s
Alzheimer Disease
Primary Senile Degenerative Dementia
Alzheimer type dementia
Senile dementia
Presenile dementia

Abbreviations Used in this Section (optional)
AD: Alzheimer’s Disease
Medical Specialties (optional)
Geriatrics, Neurology, Psychiatry
Important Sites:

One-Stop Shops
Alzheimer’s Association http://www.alz.org/
Founded in 1980, the Alzheimer’s Association is the major U.S.-based voluntary health
organization devoted to Alzheimer’s disease. The Association has local chapters and support
groups across the U.S., and is a key resource for people interested in Alzheimer’s intormation,
care, education, research, and advocacy. Users can sign up for weekly e-news (sent by e-mail or
RSS feeds.), and participate in the Association’s online communication forum. The stages of
Alzheimer’s disease are described at
http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp
ADEAR. Alzheimer’s Disease Education and Referral Center.
http://www.nia.nih.gov/Alzheimers/
ADEAR, founded in 1990 is a service of the National Institute on Aging, one of the U.S.
National Institutes of Health. It was established by the U.S. Congress to be an AD information
center for health professionals and laypeople. ADEAR is one of the best sources for reliable,
unbiased information on all aspects of Alzheimer’s disease. Most resources are free; U.S.government produced publications are not copyrighted and may be freely reproduced.
MedlinePlus: Alzheimer’s Disease. http://www.nlm.nih.gov/medlineplus/alzheimersdisease.html
MedlinePlus is the “gold standard” for reliable consumer health information on all topics, not
just Alzheimer’s diseases. Includes news, information on health conditions, a medical dictionary,
drug directory, videos, interactive tutorials and other information for various audiences,
including easy-to-read and other languages. Medlineplus has both non-copyrighted (U.S.
government-produced – may be freely reproduced) and copyrighted materials.
Other Good Sites
AARP. Alzheimer’s disease: Learning Center. http://healthtools.aarp.org/learningcenter/alzheimers-disease
Alzheimer’s Disease International. http://www.alz.co.uk/
Alzheimer’s Society (United Kingdom). http://www.alzheimers.org.uk/
Alzheimer Society (Canada). http://www.alzheimer.ca/english/index.php
Mayo Clinic. Alzheimer’s Disease. http://www.mayoclinic.com/health/alzheimersdisease/DS00161
Includes multimedia materials, blog, newsletter.

MedicineNet.com. Alzheimer’s Disease Center.
http://www.medicinenet.com/alzheimers/focus.htm
Merck Manual Home Edition. Alzheimer’s Disease.
http://www.merckmanuals.com/home/sec06/ch083/ch083c.html#sec06-ch083-ch083c-522
National Institute of Neurological Disorders and Stroke (NINDS): Alzheimer’s Disease.
http://www.ninds.nih.gov/disorders/alzheimersdisease/alzheimersdisease.htm
NIH Senior Health: Alzheimer’s Disease. http://nihseniorhealth.gov/alzheimersdisease/toc.html
U.S. government site – text size may be adjusted and accompanying audio turned on/off.
Includes videos.
WebMD. Alzheimer’s Disease Health Center. http://www.webmd.com/alzheimers/default.htm
Hotlines
Many hotlines now use Skype. Skype allows computer users to download free software from
http://www.skype.com/ and to make video phone calls free of charge if your computer has a
webcam (a device that displays your picture and lets you see the person you are calling on the
computer screen).
1(800) 272-3900 (Alzheimer’s Association). 24-hour helpline. A Skype link appears on the
association Web site.
1(800) 438-4380 (ADEAR). A Skype link appears on the ADEAR Web site.
1(866) AFA-8484 (Alzheimer’s Foundation of America). Talk to a social worker. Skype link
available.
Publications on the Internet
Alzheimer’s Association. States of Alzheimer’s.
http://www.alz.org/alzheimers_disease_stages_of_alzheimers.asp
Alzheimer’s Association. 10 Signs of Alzheimer’s.
http://www.alz.org/alzheimers_disease_10_signs_of_alzheimers.asp
Healthy People 2020. Dementias Including Alzheimer’s.
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?topicid=7
National Institute on Aging. Alzheimer’s Disease Fact Sheet.
http://www.nia.nih.gov/Alzheimers/Publications/adfact.htm

National Institute on Aging. Alzheimer’s Disease: Unraveling the Mystery (4-minute captioned
video). http://www.nia.nih.gov/Alzheimers/ADVideo/
National Institute on Aging. Understanding Alzheimer’s disease (easy to read)
http://www.nia.nih.gov/Alzheimers/Publications/UnderstandingAD/
PBS. The Forgetting: A Portrait of Alzheimer’s. (award-winning video and educational
materials). http://www.pbs.org/theforgetting/
Patient Support Organizations/Discussion Groups
Alzheimer’s Association. Support Groups.
http://www.alz.org/mglc/in_my_community_support.asp#connect_online
WebMD Alzheimer’s Community. http://exchanges.webmd.com/alzheimers-exchange

